Search results for " Malignant"

showing 10 items of 91 documents

Steroid hormone receptor analysis in human melanoma and non-malignant human skin

1982

MaleReceptors SteroidSkin NeoplasmsSteroid hormone receptorbusiness.industryReceptors Cell SurfaceNon malignantHuman skinDermatologyReceptors GlucocorticoidReceptors EstrogenImmunologyCancer researchHumansMedicineFemaleHuman melanomaProgestinsbusinessMelanomaSkinBritish Journal of Dermatology
researchProduct

The incidence of severe oral mucositis and its occurrence sites in pediatric oncologic patients

2020

Background Childhood cancer is one of the main causes of child mortality and its treatment has debilitating effects on the oral cavity. Several oral mucositis (SOM) is one of the most common and may cause undesirable symptoms such as pain and risk of systemic infection. Material and Methods This was a longitudinal, retrospective, and observational study determining the incidence of severe oral mucositis (SOM) and its occurrence sites in pediatric oncologic patients, in João Pessoa, Brazil, between 2013 and 2018. Data from 56 patients aged 1 to 18 years were collected from their medical records and through an oral mucosa examination, from the 1st to 5th week of chemotherapy treatment (CT) us…

MaleSalivamedicine.medical_specialtyAdolescentmedicine.medical_treatmentAntineoplastic AgentsGastroenterologyosteogenesisOral Cancer and Potentially malignant disordersNeoplasmsInternal medicinedental implantsmedicineMucositisHumansLabial MucosaOral mucosaChildilizarov techniqueGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesStomatitisChemotherapybusiness.industryResearchIncidenceIncidence (epidemiology)Medical recordbone lengtheningMouth MucosaInfantOdds ratiomedicine.diseasemedicine.anatomical_structureOtorhinolaryngologyChild PreschoolFemaleSurgerybusinessBrazildistraction
researchProduct

Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population

2020

Background Among the oral potentially malignant disorders, leukoplakia stands out as the most prevalent. The purpose of this study was to analyse the clinical-pathological features of oral leukoplakia in groups of patients from three major pathology centers in two different regions of Brazil, in order to determine which factors would be associated to the clinical risk of malignant transformation. Material and Methods A total of 148 patients was analyzed, and data regarding gender, age, site, classification of the clinical subtype, harmful habits such as use of tobacco and alcohol, time of evolution and presence of dysplasia were collected. The association between risk factors and malignant …

Malemedicine.medical_specialtyMalignant transformationRisk FactorsTongueOral Cancer and Potentially malignant disordersInternal medicineStatistical significancemedicineHumansGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesLeukoplakiabusiness.industryResearchRetrospective cohort studyMiddle Agedmedicine.diseasepediatric dentistryOral leukoplakiaExact testmucositisCell Transformation Neoplasticmedicine.anatomical_structureOtorhinolaryngologyDysplasiaoncologyFemaleSurgeryLeukoplakia OralbusinessBrazilMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention.

2005

Thoracentesis plays an important role in cancer patients with symptomatic effusions, although its effect is short-lived and symptoms recur in almost all patients. Early video-thoracoscopic surgical pleurodesis may provide added benefit to a group of patients with advanced cancer presenting with symptomatic malignant pleural effusion. Seventy-six patients with advanced cancer and pleural effusion due to pulmonary-pleural metastases were recruited. In 51 cases (67.1%), at least one thoracentesis was performed before admission for surgery. Preoperative staging consisted of chest radiograph, CT scan, and blood gas analysis. The mean Karnofsky performance status was about 50. Pleurodesis with ta…

Malemedicine.medical_specialtyPalliative carePleural effusionmedicine.medical_treatmentThoracentesisRisk AssessmentPostoperative ComplicationsRisk FactorsThoracoscopyMedicineMalignant pleural effusionHumansLongitudinal StudiesGeneral NursingPleurodesismedicine.diagnostic_testbusiness.industryThoracic Surgery Video-AssistedIncidenceCancerMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryPleural Effusion MalignantSurvival RateAnesthesiology and Pain MedicineTreatment OutcomeItalyTalcFemaleNeurology (clinical)RadiologybusinessChest radiographPleurodesisFollow-Up StudiesJournal of pain and symptom management
researchProduct

How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?

2015

Urinary bladder malignancies are uncommon in children. Approximately 80 children with papillary carcinoma have been described to date, presenting as papillary neoplasms of both low grade and low stage. On the basis of the 1973 World Health Organization classification, tumors were classified as transitional cell carcinoma of the urinary bladder (TCCB). Owing to more detailed histologic criteria, this term has been replaced by papillary urothelial neoplasm of low malignant potential and low-grade carcinoma of the urinary bladder in the World Health Organization-International Society of Urologic Pathology consensus classification system of urothelial neoplasms 2004. Nevertheless, TCCB still re…

Malemedicine.medical_specialtyPathologyAdolescentUrologyUrologyWorld Health OrganizationWorld healthmedicineCarcinomaHumansStage (cooking)ChildCarcinoma Renal CellPapillary urothelial neoplasm of low malignant potentialCarcinoma Transitional CellUrinary bladderbusiness.industryPapillary Neoplasmmedicine.diseasemedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsFemalePapillary carcinomaNeoplasm GradingbusinessUrology
researchProduct

Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project

2010

AbstractChanging definitions and classifications of hematologic malignancies (HMs) complicate incidence comparisons. HAEMACARE classified HMs into groupings consistent with the latest World Health Organization classification and useful for epidemiologic and public health purposes. We present crude, age-specific and age-standardized incidence rates for European HMs according to these groupings, estimated from 66 371 lymphoid malignancies (LMs) and 21 796 myeloid malignancies (MMs) registered in 2000-2002 by 44 European cancer registries, grouped into 5 regions. Age-standardized incidence rates were 24.5 (per 100 000) for LMs and 7.55 for MMs. The commonest LMs were plasma cell neoplasms (4.6…

Malemedicine.medical_specialtyPathologyChildhood leukemiaHematologic malignant; Europe; morphologic subtype; international comparison; population-based cancer registry.ImmunologyPopulationUNITED-STATESALCOHOLBiochemistryNOMyelodysplastic–myeloproliferative diseasesInternal medicineEpidemiologymorphologymedicineLYMPHOMAHumansEPIDEMIOLOGYRegistriesEXPOSUREeducationRISKeducation.field_of_studyTOBACCOhaematologic malignanciesbusiness.industryIncidence (epidemiology)IncidenceleukemiaMyeloid leukemiaCell BiologyHematologyHematologic malignancies; morphology; Europe.Plasma cell neoplasmmedicine.diseaseMyelodysplastic-Myeloproliferative DiseasesLymphomaEuropeCANCER INCIDENCEHematologic Neoplasmscancer incidence tobacco alcohol epidemiology leukemia risk exposureCHILDHOOD LEUKEMIAHematologic malignanciesFemalebusiness
researchProduct

Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells

2016

Malignant Mesothelioma is a highly aggressive cancer, which is difficult to diagnose and treat. Here we describe the molecular, cellular and morphological characterization of a syngeneic system consisting of murine AB1, AB12 and AB22 mesothelioma cells injected in immunocompetent BALB/c mice, which allows the study of the interplay of tumor cells with the immune system. Murine mesothelioma cells, like human ones, respond to exogenous High Mobility Group Box 1 protein, a Damage-Associated Molecular Pattern that acts as a chemoattractant for leukocytes and as a proinflammatory mediator. The tumors derived from AB cells are morphologically and histologically similar to human MM tumors, and res…

Mesothelioma0301 basic medicinePathologymedicine.medical_specialtyLung NeoplasmsAntineoplastic AgentsPemetrexedHMGB1DeoxycytidineArticleProinflammatory cytokineBALB/c03 medical and health sciences0302 clinical medicineImmune systemMalignant MesotheliomCell Line TumormedicineMesothelioma HMGB1 in vivo imagingcancerAnimalsHumansMesotheliomaHMGB1 ProteinCisplatinMice Inbred BALB CMultidisciplinarybiologybusiness.industryMesothelioma Malignantbiology.organism_classificationmedicine.diseaseSurvival AnalysisGemcitabine030104 developmental biologyPemetrexedCell culturemesothelioma030220 oncology & carcinogenesisbiology.proteinFemaleCisplatinBALB/cbusinessImmunocompetenceNeoplasm Transplantationmedicine.drug
researchProduct

Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A co…

2020

Abstract Background Expression of proton-coupled folate transporter (PCFT) is associated with survival of mesothelioma patients treated with pemetrexed, and is reduced by hypoxia, prompting studies to elucidate their correlation. Methods Modulation of glycolytic gene expression was evaluated by PCR arrays in tumour cells and primary cultures growing under hypoxia, in spheroids and after PCFT silencing. Inhibitors of lactate dehydrogenase (LDH-A) were tested in vitro and in vivo. LDH-A expression was determined in tissue microarrays of radically resected malignant pleural mesothelioma (MPM, N = 33) and diffuse peritoneal mesothelioma (DMPM, N = 56) patients. Results Overexpression of hypoxia…

MesotheliomaCancer ResearchPleural NeoplasmsCell Culture TechniquesPemetrexedDeoxycytidineArticle03 medical and health sciencesMice0302 clinical medicinelactate dehydrogenase inhibitorsIn vivoAntigens NeoplasmCell Line TumormedicineGene silencingAnimalsHumansMesotheliomaEnzyme InhibitorsCarbonic Anhydrase IXPeritoneal Neoplasms030304 developmental biology0303 health sciencesL-Lactate DehydrogenaseCell growthChemistryhypoxiaMesothelioma MalignantDrug SynergismHypoxia (medical)Translational researchmedicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaXenograft Model Antitumor AssaysGemcitabineGemcitabineCell HypoxiaGene Expression Regulation NeoplasticPemetrexedOncologyDrug Resistance Neoplasm030220 oncology & carcinogenesisPeritoneal mesotheliomaCancer researchFemalemedicine.symptomProton-Coupled Folate Transportermedicine.drugBritish journal of cancer
researchProduct

Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma

2016

A series of 22 derivatives of the [1,2]oxazolo[5,4-e]isoindole system were synthesized through an efficient and versatile procedure that involves the annelation of the [1,2]oxazole moiety to the isoindole ring, producing derivatives with a wide substitution pattern. The structure-activity relationship indicates that the N-4-methoxybenzyl group appears crucial for potent activity. In addition, the presence of a 6-phenyl moiety is important and the best activity is reached with a 3,4,5-trimethoxy substituent. The most active compound, bearing both the structural features, was able to inhibit tumor cell proliferation at nanomolar concentrations when tested against the full NCI human tumor cell…

MesotheliomaLung NeoplasmsMice NudeAntineoplastic AgentsApoptosisIsoindoles01 natural sciencesMiceStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIn vivoDrug DiscoveryTumor Cells CulturedAnimalsHumansMoietyPeritoneal NeoplasmsCell ProliferationOxazoleDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryCell growthMedicine (all)Drug Discovery3003 Pharmaceutical ScienceCell CycleMesothelioma MalignantNeoplasms ExperimentalSettore CHIM/08 - Chimica FarmaceuticaIn vitro0104 chemical sciencesMedicine (all); Molecular Medicine; Drug Discovery3003 Pharmaceutical ScienceBiochemistryApoptosisCell culture030220 oncology & carcinogenesisMolecular MedicineDrug Screening Assays AntitumorIsoindoleJournal of Medicinal Chemistry
researchProduct

Expression profile of components of the β-catenin destruction complex in oral dysplasia and oral cancer

2021

Background Oral cancer represents the sixth most common cancer in the world and is associated with 40-50% survival at 5 years. Within oral malignancies, oral squamous cell carcinoma (OSCC) is commonly preceded by potentially malignant lesions, which, according to histopathological criteria, are referred to as oral dysplasia and their diagnosis are associated with higher rates of malignant transformation towards cancer. We recently reported that aberrant activation of the Wnt/β‑catenin pathway is due to overexpression of Wnt ligands in oral dysplasia. However, the expression of other regulators of this pathway, namely components of the β-catenin destruction complex has not been explored in o…

Mild DysplasiaAdenomatous polyposis coliMalignant transformationmalignantOral Cancer and Potentially malignant disordersHumansMedicineWnt Signaling PathwayGeneral DentistryGSK3Bbeta CateninUNESCO:CIENCIAS MÉDICASOral DysplasiaAxin Signaling ComplexGlycogen Synthase Kinase 3 betabiologySquamous Cell Carcinoma of Head and Neckbusiness.industryResearchWnt signaling pathwayCancerfloor of the mouthmedicine.diseasestomatognathic diseasesOtorhinolaryngologyCateninCarcinoma Squamous Cellbiology.proteinCancer researchMouth NeoplasmsepidemiologySurgerybenignbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct